GlassScriptPhysician profile
Tina M Calhoun
NPI 1801056916
$2,313.74
in general payments reported to CMS, 2019-2025
21 companies · $592 in 2025
The $592 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $137 · 2021: $84.16 · 2022: $243 · 2023: $350 · 2024: $464 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $540.88 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $234.42 | 2021-2025 | Ubrelvy, Synthroid |
| Pfizer INC. | $214.70 | 2019-2025 | |
| Lilly USA, LLC | $199.48 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $184.77 | 2019-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $176.40 | 2019-2025 | Farxiga, Breztri |
| Endo Pharmaceuticals INC. | $147.46 | 2019 | |
| Merck Sharp & Dohme LLC | $112.72 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $77.53 | 2019 | |
| Glaxosmithkline, LLC. | $72.79 | 2020-2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $57.37 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.88 | 2019-2025 | Xifaxan |
| Verona Pharma, INC. | $45.02 | 2025 | Ohtuvayre |
| Digital Diagnostics INC. | $39.00 | 2020 | |
| Viatris Specialty LLC | $30.93 | 2025 | Yupelri |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $24.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.75 | 2022 | |
| Philips North America LLC | $21.49 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.54 | 2020 | |
| Sanofi Pasteur INC. | $17.68 | 2019 | |
| Genentech USA, INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Calhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.